Pharmacological sedation management in the paediatric intensive care unit

Manuel A Baarslag1, Karel Allegaert1,2, Catherijne A J Knibbe3,4

  • 1Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.

Insights

Optimal pediatric sedation management requires more research due to scarce evidence. This review highlights ongoing studies and advanced methods to improve sedative strategies for critically ill children.

Area of Science:

  • Pediatric Intensive Care
  • Pharmacology
  • Clinical Research

Background:

  • Sedation management in pediatric intensive care units (PICUs) lacks optimal evidence-based strategies.
  • Commonly used sedatives and their pharmacokinetic/pharmacodynamic profiles in children require further elucidation.

Purpose of the Study:

  • To review current knowledge on pediatric sedation management, identify knowledge gaps, and discuss ongoing research.
  • To provide an overview of sedatives, their properties, guidelines, and assessment methods in pediatric critical care.

Main Methods:

  • Literature review of sedation management in PICUs.
  • Analysis of pharmacokinetic and pharmacodynamic data for pediatric sedatives.
  • Examination of current sedation guidelines and assessment tools.

Main Results:

  • Evidence and pharmacokinetic data for pediatric sedatives are scarce.
  • Active research is generating new pharmacokinetic (PK) and pharmacodynamic (PD) data for pediatric sedatives.
  • Regulatory bodies like the FDA and EMA recognize the need for improved evidence.

Conclusions:

  • The heterogeneous nature of the pediatric population necessitates a move towards evidence- or model-based sedation practices.
  • Future research should focus on sedation assessment and the implementation of protocolized sedation strategies.
  • Improvements in pediatric sedation extend beyond pharmacology, encompassing assessment and implementation strategies.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
870
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
778
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
2.1K